Home/Filings/4/0001209191-19-015085
4//SEC Filing

van den Broek Richard 4

Accession 0001209191-19-015085

CIK 0001169245other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 5:03 PM ET

Size

11.8 KB

Accession

0001209191-19-015085

Insider Transaction Report

Form 4
Period: 2019-02-27
Transactions
  • Award

    Non-employee Director Stock Option (right to buy)

    2019-02-27+23,00023,000 total
    Exercise: $3.15Exp: 2029-02-27Common Stock (23,000 underlying)
  • Award

    Non-employee Director Stock Option (right to buy)

    2019-02-27+22,00022,000 total
    Exercise: $3.15Exp: 2029-02-27Common Stock (22,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest in equal monthly installments over 36 months from February 27, 2019, subject to the reporting person's continued service through each such date.

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1
  • filerCIK 0001431872

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:03 PM ET
Size
11.8 KB